Prediction of treatment success of dialectical behavior therapy in borderline personality disorder

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00030392

Enrollment

150

Registered

2022-10-19

Start date

2023-07-03

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F60.31

Interventions

Group 1: 150 patients with Borderline-Personality disorder receive DBT-treatment. Efficacy of treatment will be asssessed using rating scales including the Zanarini rating scale for Borderline persona

Eligibility

Sex/Gender

Female

Age

18 Years to 50 Years

Inclusion criteria

Inclusion criteria: Borderline Personality Disorder F60.31

Exclusion criteria

Exclusion criteria: Intensive experience with DBT skills training, History of brain injury, epilepsy, schizophrenia, bipolar disorder, subtstance abuse disorder during the last year. Current use of illegal drugs, current major depression, current use of benzodiazepines, general exclusion criteria for MRI (e.g. metal implants, pace maker)

Design outcomes

Primary

Measure	Time frame
Zanarini Rating Scale for Borderline Personality Disorder during treatment with weekly assessment.	—

Secondary

Measure	Time frame
Borderline-Symptome-List 23 (BSL-23) during treatment with weekly assessment. Level of Personality Functioning Scale during treatment with weekly assessment.	—

Countries

Germany

Contacts

Public ContactThomas Ethofer

Universitätsklinik für Psychiatrie und Psychotherapie Tübingen

Thomas.Ethofer@med.uni-tuebingen.de07071-2986124

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026